SEC 13F Intelligence

Orbimed Advisors LLC / BSX

Orbimed Advisors LLC’s Boston Scientific Corp Position

Does Orbimed Advisors LLC own Boston Scientific Corp (BSX)? Yes — 2.38M shares worth $149M (+2.96% of its 13F portfolio) as of Q1 2026, down from 2.42M shares the prior filed quarter.

Position Value
$149M
Q1 2026
Shares
2.38M
% of Portfolio
+2.96%
Quarters Held
30
currently held

Position History BSX

Reported value by quarter
Q4 ’18: $205MQ4 ’18Q1 ’19: $222MQ2 ’19: $290MQ3 ’19: $214MQ4 ’19: $211MQ4 ’19Q1 ’20: $158MQ2 ’20: $170MQ3 ’20: $185MQ4 ’20: $235MQ4 ’20Q1 ’21: $267MQ2 ’21: $296MQ3 ’21: $253MQ4 ’21: $236MQ4 ’21Q1 ’22: $204MQ2 ’22: $163MQ3 ’22: $151MQ4 ’22: $180MQ4 ’22Q1 ’23: $190MQ2 ’23: $183MQ3 ’23: $175MQ4 ’23: $191MQ4 ’23Q1 ’24: $224MQ2 ’24: $252MQ3 ’24: $274MQ4 ’24: $282MQ4 ’24Q1 ’25: $284MQ2 ’25: $302MQ3 ’25: $237MQ4 ’25: $231MQ4 ’25Q1 ’26: $149Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20262.38M$149M+2.96%
Q4 20252.42M$231M+4.71%
Q3 20252.43M$237M+5.57%
Q2 20252.81M$302M+7.55%
Q1 20252.81M$284M+6.77%
Q4 20243.16M$282M+5.81%
Q3 20243.27M$274M+4.98%
Q2 20243.27M$252M+4.98%
Q1 20243.27M$224M+4.11%
Q4 20233.31M$191M+3.82%
Q3 20233.31M$175M+3.71%
Q2 20233.38M$183M+3.31%
Q1 20233.79M$190M+3.72%
Q4 20223.90M$180M+3.45%
Q3 20223.90M$151M+2.80%
Q2 20224.37M$163M+2.95%
Q1 20224.60M$204M+3.30%
Q4 20215.55M$236M+3.03%
Q3 20215.83M$253M+2.78%
Q2 20216.92M$296M+2.99%
Q1 20216.92M$267M+2.50%
Q4 20206.52M$235M+2.05%
Q3 20204.85M$185M+2.33%
Q2 20204.85M$170M+2.40%
Q1 20204.85M$158M+2.66%
Q4 20194.67M$211M+3.02%
Q3 20195.27M$214M+4.07%
Q2 20196.75M$290M+4.49%
Q1 20195.79M$222M+3.44%
Q4 20185.79M$205M+3.78%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Orbimed Advisors LLC’s full portfolio or all institutional holders of BSX.